HK1093068A1 - Salts and polymorphs of a pyrrole-substituted indolinone compound - Google Patents

Salts and polymorphs of a pyrrole-substituted indolinone compound

Info

Publication number
HK1093068A1
HK1093068A1 HK06113815.0A HK06113815A HK1093068A1 HK 1093068 A1 HK1093068 A1 HK 1093068A1 HK 06113815 A HK06113815 A HK 06113815A HK 1093068 A1 HK1093068 A1 HK 1093068A1
Authority
HK
Hong Kong
Prior art keywords
polymorphs
pyrrole
salts
indolinone compound
substituted indolinone
Prior art date
Application number
HK06113815.0A
Other languages
English (en)
Inventor
A Blasko
Qingwu Q Jin
Qun Q Lu
M Mauragis
Dian D Song
Bvonderwell
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of HK1093068A1 publication Critical patent/HK1093068A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK06113815.0A 2003-10-02 2006-12-15 Salts and polymorphs of a pyrrole-substituted indolinone compound HK1093068A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50810403P 2003-10-02 2003-10-02
PCT/IB2004/003070 WO2005033098A1 (en) 2003-10-02 2004-09-20 Salts and polymorphs of a pyrrole-substituted indolinone compound

Publications (1)

Publication Number Publication Date
HK1093068A1 true HK1093068A1 (en) 2007-02-23

Family

ID=34421700

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06113815.0A HK1093068A1 (en) 2003-10-02 2006-12-15 Salts and polymorphs of a pyrrole-substituted indolinone compound

Country Status (26)

Country Link
US (1) US7247627B2 (de)
EP (1) EP1670785B1 (de)
JP (1) JP4933259B2 (de)
KR (2) KR20060058728A (de)
CN (1) CN100432072C (de)
AR (1) AR047762A1 (de)
AT (1) ATE473223T1 (de)
AU (1) AU2004277464B2 (de)
BR (1) BRPI0415022A (de)
CA (1) CA2540639C (de)
CY (1) CY1110771T1 (de)
DE (1) DE602004028028D1 (de)
DK (1) DK1670785T3 (de)
ES (1) ES2348623T3 (de)
HK (1) HK1093068A1 (de)
IL (1) IL174414A (de)
MX (1) MXPA06003661A (de)
NO (1) NO20061246L (de)
NZ (1) NZ546001A (de)
PL (1) PL1670785T3 (de)
PT (1) PT1670785E (de)
RU (1) RU2319702C2 (de)
SI (1) SI1670785T1 (de)
TW (1) TW200524921A (de)
WO (1) WO2005033098A1 (de)
ZA (1) ZA200602691B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050182122A1 (en) * 2003-11-20 2005-08-18 Bello Carlo L. Method of treating abnormal cell growth using indolinone compounds
NZ561138A (en) * 2005-03-23 2009-06-26 Pfizer Prod Inc Anti-CTLA4 antibody and indolinone combination therapy for treatment of cancer
CN101267824A (zh) * 2005-09-20 2008-09-17 辉瑞产品公司 使用酪氨酸激酶抑制剂的治疗剂型和方法
CL2008000070A1 (es) * 2007-01-17 2008-07-25 Lg Life Sciences Ltd Monosal del acido maleico (3-[({1-[(2-amino-9h-purin-9-il)metil]ciclopropil}oxi)metil]-8,8-dimetil-3,7-dioxo-2,4,6-trioxa-3 lambda 5-fosfanon-1-il-pivalato; composicion farmaceutica que comprende a dicha monosal; y uso para el tratamiento del virus h
EP2130798B1 (de) * 2007-04-04 2018-05-16 Otsuka Chemical Co., Ltd. Kaliumtitanat, verfahren zu seiner herstellung, reibungsmaterialien und harzzusammensetzungen
AU2009293444B2 (en) * 2008-09-17 2012-03-15 Sun Pharmaceutical Industries Limited Salts of N-[6-cis-2,6-dimethylmorpholin-4yl)pyridine-3yl]-2-methyl-4'- (trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide
WO2012042421A1 (en) 2010-09-29 2012-04-05 Pfizer Inc. Method of treating abnormal cell growth
US9851313B2 (en) * 2015-03-03 2017-12-26 Panalytical B.V. Quantitative X-ray analysis—ratio correction

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534522A (en) * 1995-06-07 1996-07-09 Warner-Lambert Company (R)-(Z)-1-azabicyclo [2.2.1] heptan-3-one,O-[3-(3-methoxyphenyl)-2-propynyl] oxime maleate as a pharmaceutical agent
DE19622489A1 (de) * 1996-06-05 1997-12-11 Hoechst Ag Salze des 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4- methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3- phenyl-propionsäure-ethylesters
ES2290117T3 (es) 2000-02-15 2008-02-16 Sugen, Inc. Inhibidores de proteina quinasa 2-indolina sustituida con pirrol.
AR042586A1 (es) * 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
EP3168218B1 (de) 2001-08-15 2018-11-14 Pharmacia & Upjohn Company LLC Ein kristall enthaltend ein malatsalz von n-[2-(diethylamino)ethyl]-5-[(5-fluor-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamid zur verwendung als medikament
YU67702A (sh) 2001-09-28 2004-12-31 Pfizer Products Inc. Postupak za dobijanje alkansulfonil piridina
TWI259081B (en) * 2001-10-26 2006-08-01 Sugen Inc Treatment of acute myeloid leukemia with indolinone compounds
AU2003216282A1 (en) * 2002-02-15 2003-09-09 Pharmacia And Upjohn Company Llc Process for preparing indolinone derivatives
HN2003000272A (es) * 2002-09-10 2008-07-29 Pharmacia Italia Spa Formulaciones que comprenden un compuesto de indolinona

Also Published As

Publication number Publication date
IL174414A0 (en) 2008-02-09
ATE473223T1 (de) 2010-07-15
US7247627B2 (en) 2007-07-24
EP1670785B1 (de) 2010-07-07
CA2540639C (en) 2010-08-31
ZA200602691B (en) 2007-06-27
BRPI0415022A (pt) 2006-11-28
AR047762A1 (es) 2006-02-22
RU2319702C2 (ru) 2008-03-20
PL1670785T3 (pl) 2010-12-31
IL174414A (en) 2011-12-29
CA2540639A1 (en) 2005-04-14
CN100432072C (zh) 2008-11-12
JP2007507482A (ja) 2007-03-29
US20050118255A1 (en) 2005-06-02
CN1863796A (zh) 2006-11-15
NZ546001A (en) 2009-09-25
PT1670785E (pt) 2010-09-16
AU2004277464B2 (en) 2010-07-08
DE602004028028D1 (de) 2010-08-19
RU2006110541A (ru) 2006-08-27
TW200524921A (en) 2005-08-01
NO20061246L (no) 2006-03-29
ES2348623T3 (es) 2010-12-09
EP1670785A1 (de) 2006-06-21
SI1670785T1 (sl) 2010-10-29
WO2005033098A8 (en) 2006-04-20
WO2005033098A1 (en) 2005-04-14
MXPA06003661A (es) 2006-06-05
AU2004277464A1 (en) 2005-04-14
WO2005033098A9 (en) 2006-05-26
JP4933259B2 (ja) 2012-05-16
DK1670785T3 (da) 2010-10-18
KR20060058728A (ko) 2006-05-30
KR20080007520A (ko) 2008-01-21
CY1110771T1 (el) 2015-06-10

Similar Documents

Publication Publication Date Title
HK1093068A1 (en) Salts and polymorphs of a pyrrole-substituted indolinone compound
IL180853A0 (en) Crystalline form of a biphenyl compound
PL1638416T3 (pl) Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej
IL223681A0 (en) Hydroxybenzoate salts of metanicotine compounds
IL186023A0 (en) Crystalline form of a quinolinone-carboxamide compound
HK1094190A1 (en) a polymorphic form of 3-phenylsulfonyl-8-piperazin-1-yl-quinoline
IL189809A0 (en) Glucuronate salt of a piperazine compound
HK1078852A1 (en) Method for the synthesis of a benzimidazole compound
IL187981A0 (en) Crystalline forms of a pyrrolotriazine compound
IL174551A0 (en) Resolution of a narwedine amide derivative
EP1635836A4 (de) Prodrugs von heteroaryl-verbindungen
AU2003902023A0 (en) A method of indole synthesis
EP1677781A4 (de) Salze von pharmakologisch wirksamen verbindungen
AU2003258982A8 (en) Methods of inhibiting pin1-associated states using a fredericamycin a compound
GB0325689D0 (en) A novel class of compounds
GB0309120D0 (en) A set of parts
HK1102087A1 (en) Crystalline forms of a pharmaceutical compound
IL177451A0 (en) Crystalline forms of a pharmaceutical compound
EG23601A (en) A group of scessors for opening sermony
HK1162519A1 (en) Hydroxybenzoate salts of metanicotine compounds
SI1667975T1 (sl) Polimorfna oblika 3-fenilsulfonil-8-piperazin-1-il-kinolina
AU147762S (en) A set of quilt covers
AU148636S (en) A set of quilt covers
GB0329219D0 (en) Process for the preparation of a substituted porphyrin
EP1652853A4 (de) Kristalline 6-n-pyridylmethylaminoindolocarbazolverbindung

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140920